Pharmico-gene therapy of epithelial sodium channel...

Details Pharmico-gene therapy of epithelial sodium channel... Pharmico-gene therapy of epithelial sodium channel...

A - Human Necessities

61

K

A61K 48/00 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2520016

Agents and methods to alter epithelial sodium channel (EnaC) activity.

Cette invention concerne des agents et des méthodes permettant de modifier l'activité du canal sodique épithélial (EnaC).

Affiliated with

Also associated with

Rating

Pharmico-gene therapy of epithelial sodium channel... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmico-gene therapy of epithelial sodium channel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmico-gene therapy of epithelial sodium channel... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1873787